December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

179.31 -0.74 (-0.41%)
Streaming Delayed Price Updated: 2:55 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
DaVita Inc (NYSE:DVA) Reports Mixed Q2 2025 Earnings with EPS Beat and Slight Revenue Miss ↗
DaVita Inc (NYSE:DVA) reported mixed Q2 2025 earnings, with revenue slightly missing estimates at $3.38B but EPS beating at $2.95. Stock rose modestly post-release. 
Via Chartmill
News headline image
Warren Buffett Just Bought Even More of This Dirt-Cheap Stock ↗
Berkshire Hathaway now owns 37% of this company. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings ↗
Berkshire Hathaway sold 1.64 million shares of DaVita Inc. for $230 million just before DaVita's Q2 earnings. 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Warren Buffett's Berkshire Hathaway Offloads $230M Of This Dialysis Service Provider Ahead Of Its Q2 Earnings ↗
Analysts expect a strong Q2 for DaVita, with projected year-over-year growth in revenue, EBITDA, and earnings. 
Via Stocktwits
News headline image
Earnings Scheduled For May 12, 2025 ↗
 
Via Benzinga
News headline image
DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect
Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting results this Tuesday after market hours. Here’s what to look for. 
Via StockStory
Topics World Trade
News headline image
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
Wednesday's session: top gainers and losers in the S&P500 index ↗
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug ↗
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug. 
Via Investor's Business Daily
News headline image
Winners And Losers Of Q1: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q1 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Profitable Stock Worth Your Attention and 2 to Approach with Caution
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
DVA Q1 Earnings Call: Cyber Incident, Volume Decline, and Policy Updates Shape Outlook
Dialysis provider DaVita Inc. (NYSE:DVA) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 5% year on year to $3.22 billion. Its non-GAAP EPS of $2 per share was 1% below... 
Via StockStory
News headline image
3 Value Stocks with Questionable Fundamentals
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Topics Economy
News headline image
3 S&P 500 Stocks Walking a Fine Line
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Economy Stocks
News headline image
Buffett Bought More of This High-Yield Dividend Stock in Q1. Should You Buy It, Too? ↗
Via The Motley Fool
News headline image
Made in the USA: Warren Buffett Sells Out of 1 International Stock and Doubles His Stake in 2 U.S. Companies ↗
Via The Motley Fool
News headline image
Buffett's Latest Portfolio Moves, and Another Secret Stock
Buffett's latest 13F shows no new positions in publicly traded companies, but includes a confidential mystery stake, sparking significant speculation. 
Via MarketBeat
Topics Regulatory Compliance
News headline image
Gapping S&P500 stocks in Monday's session ↗
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Warren Buffett Just Sold These 8 Stocks, One of Which Remains a Phenomenal Bargain (and a Top Holding of Mine) ↗
The Oracle of Omaha has been a big-time seller of stocks for 10 consecutive quarters -- but there's one sale he may regret. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Warren Buffett Ditches Bitcoin-Linked Nu Holdings, Adds To Constellation Brands, Domino's Pizza, Pool Corp Stakes ↗
As legendary investor Warren Buffett prepares to step down as CEO of Berkshire Hathaway Inc. 
Via Benzinga
News headline image
These S&P500 stocks have an unusual volume in today's session ↗
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session. 
Via Chartmill
News headline image
These S&P500 stocks are gapping in today's session ↗
Stay tuned for the market movements in the S&P500 index on Tuesday. Check out the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
DaVita (NYSE:DVA) Beats Q1 Sales Targets
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q1 CY2025, with sales up 5% year on year to $3.22 billion. Its non-GAAP profit of $2 per share was 1% below analysts’... 
Via StockStory
News headline image
US Stock Futures Rise As US, China Agree To 90-Day Tariff Pause: 'Wider Earnings Growth Should Drive More Balanced Market Performance,' Says Expert ↗
U.S. stock futures jumped on Monday after a muted day of trade on Friday. Futures of benchmark indices were trading over 2% in premarket. 
Via Benzinga
News headline image
Dow Falls Over 100 Points, Also Records Weekly Loss: Fear & Greed Index Remains In 'Greed' Zone ↗
 
Via Benzinga
Topics Stocks
News headline image
Fox, NRG Energy And 3 Stocks To Watch Heading Into Monday ↗
 
Via Benzinga
News headline image
Dow Futures Rally Over 400 Points As US, China 'Come To Agreement' In Geneva Trade Talks ↗
U.S. stock futures rose Sunday evening after weekend trade talks in Geneva signaled potential de-escalation in the ongoing trade war with China. 
Via Benzinga
Topics Stocks World Trade
News headline image
DaVita (DVA) Reports Earnings Tomorrow: What To Expect
Dialysis provider DaVita Inc. (NYSE:DVA) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.